Spiration® Valve System

Valve, Pulmonary

FDA Premarket Approval P180007

This medical device has supplements. The device description/function or indication may have changed. Be sure to look at the supplements to get an up-to-date information on device changes. The labeling included below is the version at time of approval of the original pma or panel track supplement and may not represent the most recent labeling.

Pre-market Approval Supplement Details

Approval of the spiration® valve system. The spiration® valves are one-way endobronchial valves indicated for adult patients with shortness of breath and hyperinflation associated with severe emphysema in regions of the lung that have low collateral ventilation.

DeviceSpiration® Valve System
Classification NameValve, Pulmonary
Generic NameValve, Pulmonary
ApplicantSpiration, Inc.
Date Received2018-02-05
Decision Date2018-12-03
Notice Date2018-12-17
PMAP180007
SupplementS
Product CodeNJK
Docket Number18M-4665
Advisory CommitteeAnesthesiology
Expedited ReviewNo
Combination Product No
Applicant Address Spiration, Inc. 6675 185th Avenue Ne redmond, WA 98052
Summary:Summary of Safety and Effectiveness
Labeling: Labeling Labeling Part 2
Post-Approval Study:Show Report Schedule and Study Progress
Approval Order: Approval Order

Supplemental Filings

Supplement NumberDateSupplement Type
P180007Original Filing
S009 2022-04-12 30-day Notice
S008 2021-04-30 Normal 180 Day Track No User Fee
S007 2020-10-21 Normal 180 Day Track No User Fee
S006
S005 2019-11-18 Normal 180 Day Track
S004
S003 2018-12-26 Normal 180 Day Track No User Fee
S002 2018-12-26 Normal 180 Day Track No User Fee
S001

NIH GUDID Devices

Device IDPMASupp
00896506002323 P180007 000
00896506002316 P180007 000
00896506002309 P180007 000
00896506002293 P180007 000
00896506002286 P180007 000
00896506002279 P180007 000

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.